Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
1 Views
administrator
07/13/23
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
-
Category
Show more
Facebook Comments
No comments found